2026-02387Notice

Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ

Published Date: 2/6/2026

Notice

Summary

The FDA has set the official review period for BEQVEZ, a new human biological product, so its patent holder can apply for extra patent time. This affects the company behind BEQVEZ and anyone interested in patent extensions. If you think the dates are wrong or want to challenge the company’s effort during review, you have until early August 2026 to speak up—no money changes hands now, but this could impact how long the patent lasts.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

FDA Sets BEQVEZ Review Period

FDA determined the regulatory review period for BEQVEZ is 3,277 days total — 2,913 days in the testing phase and 364 days in the approval phase. Key dates used were: IND effective May 8, 2015; biologics license application initially submitted April 28, 2023; and approval on April 25, 2024. This FDA determination establishes the maximum potential patent-extension period; the patent applicant is seeking 671 days of patent term extension and the USPTO will apply statutory limits in its final calculation.

Deadlines to Challenge BEQVEZ Dates

If you believe the published dates are incorrect, you must submit comments asking for a redetermination by April 7, 2026. Any interested person may petition FDA to determine whether the applicant acted with due diligence during the regulatory review period by August 5, 2026; petitions must meet the requirements of 21 CFR 60.30 and be served on the patent applicant.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
2/6/2026
4/7/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in